TruFin Staked INJ
TRUINJ
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
TRUINJ (TruFin Staked INJ) is an institutional-grade liquid staking receipt token on the Injective blockchain issued by TruFin. Overall project evaluation is constrained by significant data gaps in Community Support (-1.0) and Market and Use Case (-1.0), as public tracking and community channels could not be retrieved. On the technical and security front, TRUINJ benefits from an independent smart contract audit conducted by Zellic in November 2024, an active Immunefi bug bounty program, and a clean operational track record with no recorded hacks, exploits, depegs, or regulatory enforcement actions. Governance accountability is supported by the corporate backing of TruFin plc (publicly listed on the London Stock Exchange), though user token governance remains entirely centralized with no DAO oversight. The tokenomics present notable headwinds: while benefiting from Injective's underlying deflationary design and having no unvetted pre-mines, TRUINJ suffers from micro-scale capitalization (~$580,000), severe lack of liquidity, halted exchange trading, and permissioned/KYC-gated validator mechanics. Development activity also remains difficult to inspect directly due to the absence of public repositories and changelogs. Accounting for the redistributed weight of the missing sections, the weighted average score is 5.3/10.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About TruFin Staked INJ (TRUINJ)
TruFin Staked INJ (TRUINJ) is an institutional-grade liquid staking receipt token issued natively on the Injective blockchain. Developed by TruFin, the token is minted when whitelisted users stake INJ tokens via the protocol's staker smart contract to designated validators. TRUINJ has no fixed maximum supply, pre-mine, or private insider allocations, and it operates within the economic framework of Injective's underlying tokenomics.
TruFin's liquid staking infrastructure on Injective was independently audited by Zellic in November 2024, and the protocol maintains a bug bounty program on Immunefi. The project is backed by TruFin plc, a publicly listed company on the London Stock Exchange with named executive leadership. While the protocol maintains a clean security record with no documented smart contract exploits, hacks, depegs, or regulatory actions, governance is fully centralized under the issuing corporate entity without a decentralized autonomous organization (DAO) or on-chain voting mechanism for token holders.
TRUINJ faces operational and structural risks relating to market presence and accessibility. The token operates with permissioned, KYC-gated whitelist mechanics, leading to counterparty reliance on TruFin and its selected validator set. Furthermore, TRUINJ exhibits near-zero liquidity, halted exchange trading, and a micro-scale market capitalization of approximately $580,000, alongside limited visibility into ongoing public development and community channels.